GlassScriptPhysician profile
Maria R White
NPI 1740209857
$1,773.58
in general payments reported to CMS, 2019-2025
12 companies · $810 in 2025
The $810 reported for 2025 was more than what 82% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $397 · 2024: $567 · 2025: $810.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,774.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,773.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $519.20 | 2023-2025 | Fasenra, Breztri, Tezspire |
| Glaxosmithkline, LLC. | $402.80 | 2023-2025 | Nucala, Trelegy Ellipta |
| Genzyme Corporation | $267.28 | 2024-2025 | |
| Sanofi Pasteur INC. | $187.46 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $116.19 | 2024-2025 | Dupixent |
| Harmony Biosciences LLC | $93.26 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $77.26 | 2023 | Ofev, Stiolto Respimat |
| Pfizer INC. | $23.44 | 2023 | |
| Baxter Healthcare | $22.84 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Mallinckrodt Hospital Products INC. | $22.69 | 2023 | Acthar |
| Jazz Pharmaceuticals INC. | $21.30 | 2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $19.86 | 2023 | Glassia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maria White listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.